Calidi Biotherapeutics, Inc. Investment Income, Nonoperating
Calidi Biotherapeutics, Inc. (CLDI) reported Investment Income, Nonoperating of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2023-08-21
- Calidi Biotherapeutics, Inc. investment income, nonoperating for the quarter ending 2022-09-30 was $1.09M.
- Calidi Biotherapeutics, Inc. investment income, nonoperating for the quarter ending 2022-06-30 was $160.00K.
- Calidi Biotherapeutics, Inc. investment income, nonoperating for the quarter ending 2022-03-31 was $16.50K.
- Calidi Biotherapeutics, Inc. investment income, nonoperating for the quarter ending 2021-09-30 was $0.00.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month |
|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-21 | ||
| 2022-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.25M derived: sum of 2 quarters · filed 2023-08-21 | $1.27M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $176.50K 10-Q · filed 2023-08-21 | |
| 2022-03-31 | $16.50K 10-Q · filed 2023-05-15 | ||
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |